The global Phenylbutazone Tablets market was valued at US$ 47 million in 2023 and is anticipated to reach US$ 70 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.

Phenylbutazone Tablets Market

The market trend for Phenylbutazone Tablets is expected to see steady growth over the forecast period. Phenylbutazone is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and reduce inflammation in conditions such as arthritis. It works by inhibiting the production of certain chemicals in the body that cause pain and inflammation.One of the key factors driving the market growth is the increasing prevalence of arthritis and other musculoskeletal disorders. Arthritis affects millions of people worldwide and is a leading cause of disability. As the population continues to age and the incidence of chronic diseases rises, the demand for effective pain management options such as Phenylbutazone Tablets is expected to increase.

This report aims to provide a comprehensive presentation of the global market for Phenylbutazone Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenylbutazone Tablets.

Report Scope

The Phenylbutazone Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Phenylbutazone Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Phenylbutazone Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Phenylbutazone Tablets Market Report

Report Metric	Details
Report Name	Phenylbutazone Tablets Market
Accounted market size in 2023	US$ 47 million
Forecasted market size in 2030	US$ 70 million
CAGR	5.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	100mg 200mg
Segment by Application	Osteoarthritis Rheumatism
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AdvaCare, Dexa Medica, Guangzhou Taiceng Pharma, ShanghaixiandaiHasen(shangqiu)Pharmaceutical, Salutem Pharma, TEYI PHARMACEUTICAL, Mylan Pharmaceuticals Inc., Teva Pharmaceuticals, Qualitest Pharmaceuticals Inc., Watson Laboratories, Inc., Perrigo Pharmaceuticals, Actavis US, West-Ward Pharmaceuticals Corp.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Phenylbutazone Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Phenylbutazone Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Phenylbutazone Tablets Market growing?

Ans: The Phenylbutazone Tablets Market witnessing a CAGR of 5.9% during the forecast period 2024-2030.

What is the Phenylbutazone Tablets Market size in 2030?

Ans: The Phenylbutazone Tablets Market size in 2030 will be US$ 70 million.

Who are the main players in the Phenylbutazone Tablets Market report?

Ans: The main players in the Phenylbutazone Tablets Market are AdvaCare, Dexa Medica, Guangzhou Taiceng Pharma, ShanghaixiandaiHasen(shangqiu)Pharmaceutical, Salutem Pharma, TEYI PHARMACEUTICAL, Mylan Pharmaceuticals Inc., Teva Pharmaceuticals, Qualitest Pharmaceuticals Inc., Watson Laboratories, Inc., Perrigo Pharmaceuticals, Actavis US, West-Ward Pharmaceuticals Corp.

What are the Application segmentation covered in the Phenylbutazone Tablets Market report?

Ans: The Applications covered in the Phenylbutazone Tablets Market report are Osteoarthritis, Rheumatism

What are the Type segmentation covered in the Phenylbutazone Tablets Market report?

Ans: The Types covered in the Phenylbutazone Tablets Market report are 100mg, 200mg

1 Phenylbutazone Tablets Market Overview

1.1 Product Overview and Scope of Phenylbutazone Tablets

1.2 Phenylbutazone Tablets Segment by Type

1.2.1 Global Phenylbutazone Tablets Market Value Comparison by Type (2024-2030)

1.2.2 100mg

1.2.3 200mg

1.3 Phenylbutazone Tablets Segment by Application

1.3.1 Global Phenylbutazone Tablets Market Value by Application: (2024-2030)

1.3.2 Osteoarthritis

1.3.3 Rheumatism

1.4 Global Phenylbutazone Tablets Market Size Estimates and Forecasts

1.4.1 Global Phenylbutazone Tablets Revenue 2019-2030

1.4.2 Global Phenylbutazone Tablets Sales 2019-2030

1.4.3 Global Phenylbutazone Tablets Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Phenylbutazone Tablets Market Competition by Manufacturers

2.1 Global Phenylbutazone Tablets Sales Market Share by Manufacturers (2019-2024)

2.2 Global Phenylbutazone Tablets Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Phenylbutazone Tablets Average Price by Manufacturers (2019-2024)

2.4 Global Phenylbutazone Tablets Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Phenylbutazone Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Phenylbutazone Tablets, Product Type & Application

2.7 Phenylbutazone Tablets Market Competitive Situation and Trends

2.7.1 Phenylbutazone Tablets Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Phenylbutazone Tablets Players Market Share by Revenue

2.7.3 Global Phenylbutazone Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Phenylbutazone Tablets Retrospective Market Scenario by Region

3.1 Global Phenylbutazone Tablets Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Phenylbutazone Tablets Global Phenylbutazone Tablets Sales by Region: 2019-2030

3.2.1 Global Phenylbutazone Tablets Sales by Region: 2019-2024

3.2.2 Global Phenylbutazone Tablets Sales by Region: 2025-2030

3.3 Global Phenylbutazone Tablets Global Phenylbutazone Tablets Revenue by Region: 2019-2030

3.3.1 Global Phenylbutazone Tablets Revenue by Region: 2019-2024

3.3.2 Global Phenylbutazone Tablets Revenue by Region: 2025-2030

3.4 North America Phenylbutazone Tablets Market Facts & Figures by Country

3.4.1 North America Phenylbutazone Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Phenylbutazone Tablets Sales by Country (2019-2030)

3.4.3 North America Phenylbutazone Tablets Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Phenylbutazone Tablets Market Facts & Figures by Country

3.5.1 Europe Phenylbutazone Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Phenylbutazone Tablets Sales by Country (2019-2030)

3.5.3 Europe Phenylbutazone Tablets Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Phenylbutazone Tablets Market Facts & Figures by Country

3.6.1 Asia Pacific Phenylbutazone Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Phenylbutazone Tablets Sales by Country (2019-2030)

3.6.3 Asia Pacific Phenylbutazone Tablets Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Phenylbutazone Tablets Market Facts & Figures by Country

3.7.1 Latin America Phenylbutazone Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Phenylbutazone Tablets Sales by Country (2019-2030)

3.7.3 Latin America Phenylbutazone Tablets Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Phenylbutazone Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Phenylbutazone Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Phenylbutazone Tablets Sales by Country (2019-2030)

3.8.3 Middle East and Africa Phenylbutazone Tablets Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Phenylbutazone Tablets Sales by Type (2019-2030)

4.1.1 Global Phenylbutazone Tablets Sales by Type (2019-2024)

4.1.2 Global Phenylbutazone Tablets Sales by Type (2025-2030)

4.1.3 Global Phenylbutazone Tablets Sales Market Share by Type (2019-2030)

4.2 Global Phenylbutazone Tablets Revenue by Type (2019-2030)

4.2.1 Global Phenylbutazone Tablets Revenue by Type (2019-2024)

4.2.2 Global Phenylbutazone Tablets Revenue by Type (2025-2030)

4.2.3 Global Phenylbutazone Tablets Revenue Market Share by Type (2019-2030)

4.3 Global Phenylbutazone Tablets Price by Type (2019-2030)

5 Segment by Application

5.1 Global Phenylbutazone Tablets Sales by Application (2019-2030)

5.1.1 Global Phenylbutazone Tablets Sales by Application (2019-2024)

5.1.2 Global Phenylbutazone Tablets Sales by Application (2025-2030)

5.1.3 Global Phenylbutazone Tablets Sales Market Share by Application (2019-2030)

5.2 Global Phenylbutazone Tablets Revenue by Application (2019-2030)

5.2.1 Global Phenylbutazone Tablets Revenue by Application (2019-2024)

5.2.2 Global Phenylbutazone Tablets Revenue by Application (2025-2030)

5.2.3 Global Phenylbutazone Tablets Revenue Market Share by Application (2019-2030)

5.3 Global Phenylbutazone Tablets Price by Application (2019-2030)

6 Key Companies Profiled

6.1 AdvaCare

6.1.1 AdvaCare Corporation Information

6.1.2 AdvaCare Description and Business Overview

6.1.3 AdvaCare Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.1.4 AdvaCare Phenylbutazone Tablets Product Portfolio

6.1.5 AdvaCare Recent Developments/Updates

6.2 Dexa Medica

6.2.1 Dexa Medica Corporation Information

6.2.2 Dexa Medica Description and Business Overview

6.2.3 Dexa Medica Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Dexa Medica Phenylbutazone Tablets Product Portfolio

6.2.5 Dexa Medica Recent Developments/Updates

6.3 Guangzhou Taiceng Pharma

6.3.1 Guangzhou Taiceng Pharma Corporation Information

6.3.2 Guangzhou Taiceng Pharma Description and Business Overview

6.3.3 Guangzhou Taiceng Pharma Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Guangzhou Taiceng Pharma Phenylbutazone Tablets Product Portfolio

6.3.5 Guangzhou Taiceng Pharma Recent Developments/Updates

6.4 ShanghaixiandaiHasen(shangqiu)Pharmaceutical

6.4.1 ShanghaixiandaiHasen(shangqiu)Pharmaceutical Corporation Information

6.4.2 ShanghaixiandaiHasen(shangqiu)Pharmaceutical Description and Business Overview

6.4.3 ShanghaixiandaiHasen(shangqiu)Pharmaceutical Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.4.4 ShanghaixiandaiHasen(shangqiu)Pharmaceutical Phenylbutazone Tablets Product Portfolio

6.4.5 ShanghaixiandaiHasen(shangqiu)Pharmaceutical Recent Developments/Updates

6.5 Salutem Pharma

6.5.1 Salutem Pharma Corporation Information

6.5.2 Salutem Pharma Description and Business Overview

6.5.3 Salutem Pharma Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Salutem Pharma Phenylbutazone Tablets Product Portfolio

6.5.5 Salutem Pharma Recent Developments/Updates

6.6 TEYI PHARMACEUTICAL

6.6.1 TEYI PHARMACEUTICAL Corporation Information

6.6.2 TEYI PHARMACEUTICAL Description and Business Overview

6.6.3 TEYI PHARMACEUTICAL Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.6.4 TEYI PHARMACEUTICAL Phenylbutazone Tablets Product Portfolio

6.6.5 TEYI PHARMACEUTICAL Recent Developments/Updates

6.7 Mylan Pharmaceuticals Inc.

6.6.1 Mylan Pharmaceuticals Inc. Corporation Information

6.6.2 Mylan Pharmaceuticals Inc. Description and Business Overview

6.6.3 Mylan Pharmaceuticals Inc. Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Mylan Pharmaceuticals Inc. Phenylbutazone Tablets Product Portfolio

6.7.5 Mylan Pharmaceuticals Inc. Recent Developments/Updates

6.8 Teva Pharmaceuticals

6.8.1 Teva Pharmaceuticals Corporation Information

6.8.2 Teva Pharmaceuticals Description and Business Overview

6.8.3 Teva Pharmaceuticals Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Teva Pharmaceuticals Phenylbutazone Tablets Product Portfolio

6.8.5 Teva Pharmaceuticals Recent Developments/Updates

6.9 Qualitest Pharmaceuticals Inc.

6.9.1 Qualitest Pharmaceuticals Inc. Corporation Information

6.9.2 Qualitest Pharmaceuticals Inc. Description and Business Overview

6.9.3 Qualitest Pharmaceuticals Inc. Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Qualitest Pharmaceuticals Inc. Phenylbutazone Tablets Product Portfolio

6.9.5 Qualitest Pharmaceuticals Inc. Recent Developments/Updates

6.10 Watson Laboratories, Inc.

6.10.1 Watson Laboratories, Inc. Corporation Information

6.10.2 Watson Laboratories, Inc. Description and Business Overview

6.10.3 Watson Laboratories, Inc. Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Watson Laboratories, Inc. Phenylbutazone Tablets Product Portfolio

6.10.5 Watson Laboratories, Inc. Recent Developments/Updates

6.11 Perrigo Pharmaceuticals

6.11.1 Perrigo Pharmaceuticals Corporation Information

6.11.2 Perrigo Pharmaceuticals Phenylbutazone Tablets Description and Business Overview

6.11.3 Perrigo Pharmaceuticals Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Perrigo Pharmaceuticals Phenylbutazone Tablets Product Portfolio

6.11.5 Perrigo Pharmaceuticals Recent Developments/Updates

6.12 Actavis US

6.12.1 Actavis US Corporation Information

6.12.2 Actavis US Phenylbutazone Tablets Description and Business Overview

6.12.3 Actavis US Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Actavis US Phenylbutazone Tablets Product Portfolio

6.12.5 Actavis US Recent Developments/Updates

6.13 West-Ward Pharmaceuticals Corp.

6.13.1 West-Ward Pharmaceuticals Corp. Corporation Information

6.13.2 West-Ward Pharmaceuticals Corp. Phenylbutazone Tablets Description and Business Overview

6.13.3 West-Ward Pharmaceuticals Corp. Phenylbutazone Tablets Sales, Revenue and Gross Margin (2019-2024)

6.13.4 West-Ward Pharmaceuticals Corp. Phenylbutazone Tablets Product Portfolio

6.13.5 West-Ward Pharmaceuticals Corp. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Phenylbutazone Tablets Industry Chain Analysis

7.2 Phenylbutazone Tablets Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Phenylbutazone Tablets Production Mode & Process

7.4 Phenylbutazone Tablets Sales and Marketing

7.4.1 Phenylbutazone Tablets Sales Channels

7.4.2 Phenylbutazone Tablets Distributors

7.5 Phenylbutazone Tablets Customers

8 Phenylbutazone Tablets Market Dynamics

8.1 Phenylbutazone Tablets Industry Trends

8.2 Phenylbutazone Tablets Market Drivers

8.3 Phenylbutazone Tablets Market Challenges

8.4 Phenylbutazone Tablets Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Dexa Medica

Salutem Pharma

Teyi Pharmaceutical

Guangzhou Taiceng Pharma

ShanghaixiandaiHasen(shangqiu)Pharmaceutical

Mylan Pharmaceuticals Inc.

Teva Pharmaceuticals

WATSON LABORATORIES INC.

Perrigo Pharmaceuticals

West-Ward Pharmaceuticals Corp

Qualitest Pharmaceuticals Inc.

Actavis US

AdvaCare

List of Tables

Table 1. Global Phenylbutazone Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Phenylbutazone Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Phenylbutazone Tablets Market Competitive Situation by Manufacturers in 2023

Table 4. Global Phenylbutazone Tablets Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Phenylbutazone Tablets Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Phenylbutazone Tablets Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Phenylbutazone Tablets Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Phenylbutazone Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Phenylbutazone Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Phenylbutazone Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Phenylbutazone Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Phenylbutazone Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Phenylbutazone Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenylbutazone Tablets as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Phenylbutazone Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Phenylbutazone Tablets Sales by Region (2019-2024) & (K Units)

Table 18. Global Phenylbutazone Tablets Sales Market Share by Region (2019-2024)

Table 19. Global Phenylbutazone Tablets Sales by Region (2025-2030) & (K Units)

Table 20. Global Phenylbutazone Tablets Sales Market Share by Region (2025-2030)

Table 21. Global Phenylbutazone Tablets Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Phenylbutazone Tablets Revenue Market Share by Region (2019-2024)

Table 23. Global Phenylbutazone Tablets Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Phenylbutazone Tablets Revenue Market Share by Region (2025-2030)

Table 25. North America Phenylbutazone Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Phenylbutazone Tablets Sales by Country (2019-2024) & (K Units)

Table 27. North America Phenylbutazone Tablets Sales by Country (2025-2030) & (K Units)

Table 28. North America Phenylbutazone Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Phenylbutazone Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Phenylbutazone Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Phenylbutazone Tablets Sales by Country (2019-2024) & (K Units)

Table 32. Europe Phenylbutazone Tablets Sales by Country (2025-2030) & (K Units)

Table 33. Europe Phenylbutazone Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Phenylbutazone Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Phenylbutazone Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Phenylbutazone Tablets Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Phenylbutazone Tablets Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Phenylbutazone Tablets Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Phenylbutazone Tablets Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Phenylbutazone Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Phenylbutazone Tablets Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Phenylbutazone Tablets Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Phenylbutazone Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Phenylbutazone Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Phenylbutazone Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Phenylbutazone Tablets Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Phenylbutazone Tablets Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Phenylbutazone Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Phenylbutazone Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Phenylbutazone Tablets Sales (K Units) by Type (2019-2024)

Table 51. Global Phenylbutazone Tablets Sales (K Units) by Type (2025-2030)

Table 52. Global Phenylbutazone Tablets Sales Market Share by Type (2019-2024)

Table 53. Global Phenylbutazone Tablets Sales Market Share by Type (2025-2030)

Table 54. Global Phenylbutazone Tablets Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Phenylbutazone Tablets Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Phenylbutazone Tablets Revenue Market Share by Type (2019-2024)

Table 57. Global Phenylbutazone Tablets Revenue Market Share by Type (2025-2030)

Table 58. Global Phenylbutazone Tablets Price (US$/Unit) by Type (2019-2024)

Table 59. Global Phenylbutazone Tablets Price (US$/Unit) by Type (2025-2030)

Table 60. Global Phenylbutazone Tablets Sales (K Units) by Application (2019-2024)

Table 61. Global Phenylbutazone Tablets Sales (K Units) by Application (2025-2030)

Table 62. Global Phenylbutazone Tablets Sales Market Share by Application (2019-2024)

Table 63. Global Phenylbutazone Tablets Sales Market Share by Application (2025-2030)

Table 64. Global Phenylbutazone Tablets Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Phenylbutazone Tablets Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Phenylbutazone Tablets Revenue Market Share by Application (2019-2024)

Table 67. Global Phenylbutazone Tablets Revenue Market Share by Application (2025-2030)

Table 68. Global Phenylbutazone Tablets Price (US$/Unit) by Application (2019-2024)

Table 69. Global Phenylbutazone Tablets Price (US$/Unit) by Application (2025-2030)

Table 70. AdvaCare Corporation Information

Table 71. AdvaCare Description and Business Overview

Table 72. AdvaCare Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. AdvaCare Phenylbutazone Tablets Product

Table 74. AdvaCare Recent Developments/Updates

Table 75. Dexa Medica Corporation Information

Table 76. Dexa Medica Description and Business Overview

Table 77. Dexa Medica Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Dexa Medica Phenylbutazone Tablets Product

Table 79. Dexa Medica Recent Developments/Updates

Table 80. Guangzhou Taiceng Pharma Corporation Information

Table 81. Guangzhou Taiceng Pharma Description and Business Overview

Table 82. Guangzhou Taiceng Pharma Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Guangzhou Taiceng Pharma Phenylbutazone Tablets Product

Table 84. Guangzhou Taiceng Pharma Recent Developments/Updates

Table 85. ShanghaixiandaiHasen(shangqiu)Pharmaceutical Corporation Information

Table 86. ShanghaixiandaiHasen(shangqiu)Pharmaceutical Description and Business Overview

Table 87. ShanghaixiandaiHasen(shangqiu)Pharmaceutical Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. ShanghaixiandaiHasen(shangqiu)Pharmaceutical Phenylbutazone Tablets Product

Table 89. ShanghaixiandaiHasen(shangqiu)Pharmaceutical Recent Developments/Updates

Table 90. Salutem Pharma Corporation Information

Table 91. Salutem Pharma Description and Business Overview

Table 92. Salutem Pharma Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Salutem Pharma Phenylbutazone Tablets Product

Table 94. Salutem Pharma Recent Developments/Updates

Table 95. TEYI PHARMACEUTICAL Corporation Information

Table 96. TEYI PHARMACEUTICAL Description and Business Overview

Table 97. TEYI PHARMACEUTICAL Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. TEYI PHARMACEUTICAL Phenylbutazone Tablets Product

Table 99. TEYI PHARMACEUTICAL Recent Developments/Updates

Table 100. Mylan Pharmaceuticals Inc. Corporation Information

Table 101. Mylan Pharmaceuticals Inc. Description and Business Overview

Table 102. Mylan Pharmaceuticals Inc. Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Mylan Pharmaceuticals Inc. Phenylbutazone Tablets Product

Table 104. Mylan Pharmaceuticals Inc. Recent Developments/Updates

Table 105. Teva Pharmaceuticals Corporation Information

Table 106. Teva Pharmaceuticals Description and Business Overview

Table 107. Teva Pharmaceuticals Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Teva Pharmaceuticals Phenylbutazone Tablets Product

Table 109. Teva Pharmaceuticals Recent Developments/Updates

Table 110. Qualitest Pharmaceuticals Inc. Corporation Information

Table 111. Qualitest Pharmaceuticals Inc. Description and Business Overview

Table 112. Qualitest Pharmaceuticals Inc. Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Qualitest Pharmaceuticals Inc. Phenylbutazone Tablets Product

Table 114. Qualitest Pharmaceuticals Inc. Recent Developments/Updates

Table 115. Watson Laboratories, Inc. Corporation Information

Table 116. Watson Laboratories, Inc. Description and Business Overview

Table 117. Watson Laboratories, Inc. Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Watson Laboratories, Inc. Phenylbutazone Tablets Product

Table 119. Watson Laboratories, Inc. Recent Developments/Updates

Table 120. Perrigo Pharmaceuticals Corporation Information

Table 121. Perrigo Pharmaceuticals Description and Business Overview

Table 122. Perrigo Pharmaceuticals Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Perrigo Pharmaceuticals Phenylbutazone Tablets Product

Table 124. Perrigo Pharmaceuticals Recent Developments/Updates

Table 125. Actavis US Corporation Information

Table 126. Actavis US Description and Business Overview

Table 127. Actavis US Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Actavis US Phenylbutazone Tablets Product

Table 129. Actavis US Recent Developments/Updates

Table 130. West-Ward Pharmaceuticals Corp. Corporation Information

Table 131. West-Ward Pharmaceuticals Corp. Description and Business Overview

Table 132. West-Ward Pharmaceuticals Corp. Phenylbutazone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. West-Ward Pharmaceuticals Corp. Phenylbutazone Tablets Product

Table 134. West-Ward Pharmaceuticals Corp. Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Phenylbutazone Tablets Distributors List

Table 138. Phenylbutazone Tablets Customers List

Table 139. Phenylbutazone Tablets Market Trends

Table 140. Phenylbutazone Tablets Market Drivers

Table 141. Phenylbutazone Tablets Market Challenges

Table 142. Phenylbutazone Tablets Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Phenylbutazone Tablets

Figure 2. Global Phenylbutazone Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Phenylbutazone Tablets Market Share by Type in 2023 & 2030

Figure 4. 100mg Product Picture

Figure 5. 200mg Product Picture

Figure 6. Global Phenylbutazone Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Phenylbutazone Tablets Market Share by Application in 2023 & 2030

Figure 8. Osteoarthritis

Figure 9. Rheumatism

Figure 10. Global Phenylbutazone Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Phenylbutazone Tablets Market Size (2019-2030) & (US$ Million)

Figure 12. Global Phenylbutazone Tablets Sales (2019-2030) & (K Units)

Figure 13. Global Phenylbutazone Tablets Average Price (US$/Unit) & (2019-2030)

Figure 14. Phenylbutazone Tablets Report Years Considered

Figure 15. Phenylbutazone Tablets Sales Share by Manufacturers in 2023

Figure 16. Global Phenylbutazone Tablets Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Phenylbutazone Tablets Players: Market Share by Revenue in 2023

Figure 18. Phenylbutazone Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Phenylbutazone Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Phenylbutazone Tablets Sales Market Share by Country (2019-2030)

Figure 21. North America Phenylbutazone Tablets Revenue Market Share by Country (2019-2030)

Figure 22. United States Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Phenylbutazone Tablets Sales Market Share by Country (2019-2030)

Figure 25. Europe Phenylbutazone Tablets Revenue Market Share by Country (2019-2030)

Figure 26. Germany Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Phenylbutazone Tablets Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Phenylbutazone Tablets Revenue Market Share by Region (2019-2030)

Figure 33. China Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America Phenylbutazone Tablets Sales Market Share by Country (2019-2030)

Figure 41. Latin America Phenylbutazone Tablets Revenue Market Share by Country (2019-2030)

Figure 42. Mexico Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Phenylbutazone Tablets Sales Market Share by Country (2019-2030)

Figure 46. Middle East & Africa Phenylbutazone Tablets Revenue Market Share by Country (2019-2030)

Figure 47. Turkey Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. UAE Phenylbutazone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Global Sales Market Share of Phenylbutazone Tablets by Type (2019-2030)

Figure 51. Global Revenue Market Share of Phenylbutazone Tablets by Type (2019-2030)

Figure 52. Global Phenylbutazone Tablets Price (US$/Unit) by Type (2019-2030)

Figure 53. Global Sales Market Share of Phenylbutazone Tablets by Application (2019-2030)

Figure 54. Global Revenue Market Share of Phenylbutazone Tablets by Application (2019-2030)

Figure 55. Global Phenylbutazone Tablets Price (US$/Unit) by Application (2019-2030)

Figure 56. Phenylbutazone Tablets Value Chain

Figure 57. Phenylbutazone Tablets Production Process

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Distributors Profiles

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions